Ferrigno Dean 4
4 · Sorrento Therapeutics, Inc. · Filed Sep 18, 2017
Insider Transaction Report
Form 4
Ferrigno Dean
Chief Accounting Officer
Transactions
- Award
Stock Options
2017-09-14+25,000→ 25,000 totalExercise: $1.80Exp: 2027-09-14→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]1/4 of the original number of shares subject to the option shall vest on September 14, 2018 and 1/48 of the original number of shares subject to the option shall vest following each one month period of service after September 14, 2018, subject to the Reporting Person's continued service to the Issuer through each such vesting date.